Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-21
    E.g., 2018-10-21

Archive Search

2 results
10:47 AM, Jun 21, 2017  |  BC Extra | Financial News

Autoimmune play Syntimmune raises $50M

By early next year, Syntimmune expects top-line data from Phase Ib/IIa testing of lead candidate SYNT001
6:24 PM, Mar 22, 2016  |  BC Extra | Financial News

Syntimmune raises second series A tranche

company said it achieved preclinical proof-of-concept and completed preclinical safety testing of its lead program, SYNT001
Syntimmune said the new tranche will enable it to complete a Phase Ia trial of SYNT001